BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21355726)

  • 21. Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan, and Sweden.
    Geistanger A; Arends S; Berding C; Hoshino T; Jeppsson JO; Little R; Siebelder C; Weykamp C;
    Clin Chem; 2008 Aug; 54(8):1379-85. PubMed ID: 18539643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desirable performance standards for HbA(1c) analysis - precision, accuracy and standardisation: consensus statement of the Australasian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologists of Australasia (RCPA), Endocrine Society of Australia (ESA), and the Australian Diabetes Educators Association (ADEA).
    Goodall I; Colman PG; Schneider HG; McLean M; Barker G
    Clin Chem Lab Med; 2007; 45(8):1083-97. PubMed ID: 17579563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes.
    McCarter RJ; Hempe JM; Gomez R; Chalew SA
    Diabetes Care; 2004 Jun; 27(6):1259-64. PubMed ID: 15161772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management.
    Heisler M; Piette JD; Spencer M; Kieffer E; Vijan S
    Diabetes Care; 2005 Apr; 28(4):816-22. PubMed ID: 15793179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A change of units for HbA(1c).
    Drug Ther Bull; 2010 Feb; 48(2):23-4. PubMed ID: 20147433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes.
    Kilpatrick ES; Rigby AS; Goode K; Atkin SL
    Diabetologia; 2007 Dec; 50(12):2553-61. PubMed ID: 17882397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HbA1c standardisation: history, science and politics.
    John WG; Mosca A; Weykamp C; Goodall I
    Clin Biochem Rev; 2007 Nov; 28(4):163-8. PubMed ID: 18392123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study. The DCCT Research Group.
    Clin Chem; 1987 Dec; 33(12):2267-71. PubMed ID: 3319291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of glycated haemoglobin HbA(1c) for the early detection of diabetes in high-risk subjects.
    Kim KS; Kim SK; Lee YK; Park SW; Cho YW
    Diabet Med; 2008 Aug; 25(8):997-1000. PubMed ID: 18959616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycated hemoglobin standardization--National Glycohemoglobin Standardization Program (NGSP) perspective.
    Little RR
    Clin Chem Lab Med; 2003 Sep; 41(9):1191-8. PubMed ID: 14598869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control.
    Zhang L; Krzentowski G; Albert A; Lefebvre PJ
    Diabetes Care; 2001 Jul; 24(7):1275-9. PubMed ID: 11423515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QA aspects for HbA1c measurements.
    Higgins TN
    Clin Biochem; 2008 Jan; 41(1-2):88-90. PubMed ID: 18036579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Undiagnosed diabetes mellitus and metabolic control assessed by HbA(1c) among residents of nursing homes.
    Hauner H; Kurnaz AA; Haastert B; Groschopp C; Feldhoff KH
    Exp Clin Endocrinol Diabetes; 2001; 109(6):326-9. PubMed ID: 11571670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delay in diagnosis of diabetes mellitus due to inaccurate use of hemoglobin A1C levels.
    Arnold JG; McGowan HJ
    J Am Board Fam Med; 2007; 20(1):93-6. PubMed ID: 17204741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of stable HbA(1c) for supportive marker to diagnose diabetes mellitus in Japanese subjects.
    Tanaka Y; Atsumi Y; Matsuoka K; Mokubo A; Asahina T; Hosokawa K; Shimada S; Matsunaga H; Takagi M; Ogawa O; Onuma T; Kawamori R
    Diabetes Res Clin Pract; 2001 Jul; 53(1):41-5. PubMed ID: 11378212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the DCA Vantage analyzer for HbA 1c assay.
    Szymezak J; Leroy N; Lavalard E; Gillery P
    Clin Chem Lab Med; 2008; 46(8):1195-8. PubMed ID: 18588431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel approach for the analysis of glycated hemoglobin using capillary isoelectric focusing with chemical mobilization.
    Vincenzi Jager A; Franco Maggi Tavares M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Mar; 785(2):285-92. PubMed ID: 12554141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study.
    Steffes M; Cleary P; Goldstein D; Little R; Wiedmeyer HM; Rohlfing C; England J; Bucksa J; Nowicki M
    Clin Chem; 2005 Apr; 51(4):753-8. PubMed ID: 15684277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of HBA1C measurement on Architect CI8200 (Abbott Diagnostic). Comparison with HPLC D-10 Bio-Rad assay].
    Beaune G; Ducruet J; Jund J; Favre S
    Ann Biol Clin (Paris); 2009; 67(1):101-7. PubMed ID: 19189890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.